###### Strengths and limitations of this study

-   This prospective observational cohort study focused on medical patients with sepsis and was conducted at a university hospital in China.

-   The impact of body mass index on 90-day survival of medical patients with sepsis was evaluated by Cox proportional hazard regression analysis and Kaplan-Meier survival analysis.

-   Our analyses were limited by the use of weight ascertained at intensive care unit admission rather than the patient's baseline outpatient body weight.

Introduction {#s1}
============

Sepsis is a major cause of morbidity and mortality worldwide.[@R1] Of these patients, half are treated in the intensive care unit (ICU).[@R2] In a national population-based study of sepsis in Spain, medical diagnostic categories made up the majority of causes of sepsis, while surgical diagnoses were identified in only 26% of cases.[@R3]

Body mass index (BMI) is a simple index of weight-for-height that is commonly used to classify whether adults are underweight, overweight and obese.[@R4] Several studies have examined the effects of BMI on mortality with conflicting conclusions. Lower mortality in the obese has been observed in some studies,[@R5] but some researchers believe that the true paradox may lie in the variations in sepsis interventions, such as the administration of resuscitation fluids and antimicrobial therapy.[@R6] In other studies, morbidly obese and underweight patients have been shown to be associated with higher mortality.[@R10] Thus, the impact of BMI on survival of patients with sepsis is still controversial.[@R12]

As the relationship between BMI and clinical outcomes of sepsis is complex, we therefore set out to evaluate prospectively the impact of BMI on survival in a cohort of medical patients with sepsis admitted to the medical ICU in a university hospital.

Patients and methods {#s2}
====================

Design {#s2a}
------

This was a prospective cohort study, which was conducted in the medical ICU of a university-affiliated urban teaching hospital in China from May 2015 to April 2017.

Subjects {#s2b}
--------

Sepsis was defined as the presence (probable or documented) of infection together with systemic manifestations of infection.[@R14] Hospitalised patients admitted to the medical ICU with sepsis acquired in the community or in a hospital were eligible for the study if they met any of the following criteria of severe sepsis[@R14]: (1) sepsis-induced hypotension, (2) lactate above upper laboratory level limits (1.5 mmol/L in this study), (3) urine output \<0.5 mL Kg^-1^ h^-1^ for more than 2 hours despite adequate fluid resuscitation, (4) acute lung injury with Pao~2~/Fio~2~ \<250 in the absence of pneumonia as infection source, (5) acute lung injury with Pao~2~/Fio~2~ \<200 in the presence of pneumonia as infection source, (6) creatinine \>2.0 mg/dL (176.8 µmol/L), (7) bilirubin \>2 mg/dL (34.2 µmol/L), (8) platelet count \<100 000 µL and (9) coagulopathy (international normalised ratio (INR) \>1.5).

Patients were excluded from the study if they met one of the following criteria: (1) the patient had sepsis that required surgical treatment or was caused by a surgical procedure-related infection, (2) age \<18 years, (3) the patient had a positive HIV antibody titre or had known/suspected tuberculosis at baseline, (4) expected lifespan \<3 months due to severe pre-existing comorbidities, (5) active do not resuscitate or do not intubate order and (6) pregnant.

All patients accepted treatment according to the international guidelines for management of sepsis and septic shock.[@R14] We collected the following demographic and clinical data: patient's gender, age, weight, height, primary site of infection, community-acquired or hospital-acquired infection, blood pressure, lactate level, urine output, Pao~2~/Fio~2~, serum creatinine, total bilirubin, platelets, INR, Glasgow Coma Scale, Sequential Organ Failure Assessment (SOFA) score, Acute Physiology and Chronic Health Evaluation (APACHE) II score, non-invasive ventilation, intubation, positive blood culture, length of ICU stay and length of hospital stay. Those who survived to discharge were followed for at least 90 days.

BMI is defined as the weight in kilograms divided by the square of the height in metres (kg/m^2^). Using the WHO criteria for designation of BMI,[@R4] patients were classified as underweight (BMI \<18.50 kg/m^2^), normal weight (BMI=18.50 to 24.99 kg/m^2^), overweight (BMI=25.0 to 29.99 kg/m^2^) and obese (BMI ≥30.0 kg/m^2^).

Outcomes {#s2c}
--------

The primary outcome was 90-day mortality, while the secondary outcomes were in-hospital mortality, length of ICU stay and length of hospital stay.

Statistical analysis {#s2d}
--------------------

Continuous variables were expressed as median (IQR) and categorical variables as numbers (%). Clinical data were compared between the in-hospital survivors and non-survivors. Continuous variables were compared using the non-parametric Mann-Whitney U test, and categorical variables were compared using the Χ ^2^ test. Cox proportional hazard regression analysis was undertaken to assess the factors associated with 90-day mortality. The variables significantly associated with 90-day non-survival in the univariate analysis were used in the Cox proportional hazard regression analysis.

Patients were divided into four groups based on BMI (underweight, normal, overweight and obese). Clinical data were compared among the four groups, where continuous variables were compared using the non-parametric Kruskal-Wallis H test, and categorical variables were compared using the Χ^2^ test. Kaplan-Meier survival curves were constructed to show the survival probabilities at day 90 according to BMI classification and compared using the log rank test.

All analyses were conducted using SPSS, V.22.0 (IBM). A p value \<0.05 was considered significant.

Patient involvement {#s2e}
-------------------

No patients were involved in developing the hypothesis, the specific aims or the research questions, nor were they involved in the design or implementation of this study. No patients were involved in the interpretation of study results or write up of the manuscript. There are no plans to involve patients in the dissemination of results.

Results {#s3}
=======

[Figure 1](#F1){ref-type="fig"} shows the patient selection process. In total, 178 medical patients with sepsis were included in this study, with male patients accounting for 65.2% (n=116). The median age (IQR) was 78 (66--84) years, and most patients were at least 65 years old (137/178, 77.0%). The most common primary site of infection was the lung (131 cases, 73.6%), followed by abdomen (15 cases, 8.4%), urinary tract (13 cases, 7.3%), gastrointestinal tract (12 cases, 6.7%) and other sites (7 cases, 3.9%). Patients with septic shock accounted for 33.1% (59 cases). Blood culture was positive in 38 patients (21.3%). The 90-day mortality was 47.2% (84/178 cases), and the in-hospital mortality was 41.6% (74/178 cases). The length of ICU stay and the length of hospital stay were 12 (5--22) and 15 (9--28) days, respectively.

![Patient selection. ICU, intensive care unit.](bmjopen-2018-021979f01){#F1}

Compared with in-hospital survivors, non-survivors had significantly lower BMI and Pao~2~/Fio~2~ (both p\<0.05), higher lactate, bilirubin, INR, SOFA score and APACHE II score (all p\<0.05). Meanwhile, more patients died with healthcare-acquired infections, hypotension, oliguria, septic shock and intubation (all p\<0.05) ([table 1](#T1){ref-type="table"}).

###### 

Comparison of demographics and clinical data between groups defined by in-hospital clinical outcome in 178 patients with sepsis

  ----------------------------------------------------------------------------------------
  Characteristics                  Survivors\             Non-survivors\        P values
                                   (n=104)                (n=74)                
  -------------------------------- ---------------------- --------------------- ----------
  Age (year)                       78.0 (60.0--84.0)      78.0 (69.0--84.0)     0.291

  Men                              67 (64.4)              49 (66.2)             0.805

  Body mass index (kg/m^2^)        23.2 (20.4--26.1)      21.7 (18.4--24.2)     0.006

  Comorbidities                                                                 

   COPD                            23 (22.1)              9 (12.2)              0.088

   Diabetes mellitus               26 (25.0)              21 (28.4)             0.614

   Hypertension                    47 (45.2)              31 (41.9)             0.662

   Cerebrovascular disease         30 (28.8)              15 (20.3)             0.194

   Neoplasm                        18 (17.3)              12 (16.2)             0.848

   Liver disease                   5 (4.8)                4 (5.4)               1.000

   Heart failure                   20 (19.2)              14 (18.9)             0.958

   Chronic renal failure           18 (17.3)              11 (14.9)             0.664

  Smoking (pack years)             0 (0--30.0)            0 (0--16.3)           0.509

  Primary site of infection                                                     

   Lung                            77 (74.0)              54 (73.0)             0.874

   Abdomen                         10 (9.6)               5 (6.8)               0.499

   Urinary tract                   7 (6.7)                6 (8.1)               0.728

   Gastrointestinal tract          7 (6.7)                5 (6.8)               1.000

   Other site                      3 (2.9)                4 (5.4)               0.452

  Community-acquired infection     85 (81.7)              50 (67.6)             0.030

  Hypotension                      22 (21.2)              41 (55.4)             \<0.001

  Lactate level (mmol/L)           1.8 (1.0--3.4)         2.7 (1.5--5.7)        0.001

  Oliguria                         8 (7.7)                16 (21.6)             0.007

  Pao~2~/Fio~2~ (mm Hg)            198.5 (119.3--287.5)   152.5 (99.6--210.3)   0.006

  Serum creatinine (µmol/L)        97.0 (68.3--176.3)     108.5 (64.0--194.3)   0.868

  Total bilirubin (µmol/mL)        13.1 (9.9--22.3)       18.0 (12.5--32.8)     0.015

  Platelets (×10^9^/L)             161.0 (95.8--232.5)    123.0 (75.0--204.3)   0.067

  INR                              1.2 (1.0--1.4)         1.3 (1.1--1.6)        0.015

  Glasgow Coma Scale               15.0 (10.0--15.0)      13.0 (10.0--15.0)     0.117

  SOFA score                       5.0 (4.0--7.0)         9.0 (7.0--11.0)       \<0.001

  APACHE II score                  16.0 (12.0--22.0)      21.0 (17.0--30.0)     \<0.001

  Septic shock                     21 (20.2)              38 (51.4)             \<0.001

  Non-invasive ventilation         28 (26.9)              24 (32.4)             0.426

  Intubated                        36 (34.6)              43 (58.1)             0.002

  Positive blood culture           19 (18.3)              19 (25.7)             0.235

  Length of ICU stay (days)        12.0 (6.0--22.0)       12.0 (3.0--25.0)      0.521

  Length of hospital stay (days)   18.0 (10.0--30.0)      13.0 (3.0--25.0)      0.009
  ----------------------------------------------------------------------------------------

Data are presented as n (%) or median (IQR) unless stated otherwise.

APACHE, Acute Physiology and Chronic Health evaluation; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; INR, international normalised ratio; SOFA, Sequential Organ Failure Assessment.

Cox proportional hazard regression analysis was conducted, and the independent factors for 90-day death were identified as SOFA score (HR=1.220, p\<0.001), APACHE II score (HR=1.050, p\<0.001) and BMI (HR=0.940, p=0.029) ([table 2](#T2){ref-type="table"}).

###### 

Risk factors for 90-day mortality of patients with sepsis or septic shock by Cox regression analysis

  Variables                   HR (95% CI)              P values
  --------------------------- ------------------------ ----------
  Body mass index (kg/m^2^)   0.940 (0.889 to 0.994)   0.029
  Hypotension                 0.781 (0.229 to 2.670)   0.694
  Lactate level (mmol/L)      1.018 (0.943 to 1.098)   0.648
  Oliguria                    1.288 (0.715 to 2.321)   0.399
  Pao~2~/Fio~2~ (mm Hg)       1.000 (0.997 to 1.002)   0.933
  Septic shock                1.075 (0.320 to 3.615)   0.907
  SOFA score                  1.229 (1.123 to 1.345)   \<0.001
  APACHE II score             1.050 (1.022 to 1.080)   \<0.001
  Intubated                   1.511 (0.931 to 2.452)   0.095

APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.

The variables significantly associated with 90-day non-survival in the univariate analysis were used in the Cox proportional hazard regression analysis.

Patients were divided into four groups based on BMI (underweight 33 (18.5%), normal 98 (55.1%), overweight 36 (20.2%) and obese 11 (6.2%)). The percentage of men (72.7%, 71.4%, 55.6% and 18.2%, p=0.002), chronic obstructive pulmonary disease (24.2%, 21.4%, 0 and 27.3%, p=0.017), hypotension (57.6%, 34.7%, 25.0% and 9.1%, p=0.007), septic shock (57.6%, 30.6%, 25.0% and 9.1%, p=0.004), in-hospital mortality (60.6%, 41.8%, 30.6% and 18.2%, p=0.027) and 90-day mortality (66.7%, 48.0%, 36.1% and 18.2%, p=0.015) were statistically different among the four groups ([table 3](#T3){ref-type="table"}).

###### 

Comparison of demographics and clinical data among groups defined by body mass index in patients with sepsis

  ---------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                  Underweight\           Normal\                Overweight\            Obese\                 P values
                                   (n=33)                 (n=98)                 (n=36)                 (n=11)                 
  -------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------
  Age (years)                      79.0 (69.0--86.0)      78.0 (67.0--84.0)      73.0 (57.0--83.0)      77.0 (71.0--86.0)      0.162

  Males                            24 (72.7)              70 (71.4)              20 (55.6)              2 (18.2)               0.002

  Comorbidities                                                                                                                

   COPD                            8 (24.2)               21 (21.4)              0                      3 (27.3)               0.017

   Diabetes mellitus               8 (24.2)               25 (25.5)              9 (25.0)               5 (45.5)               0.530

   Hypertension                    14 (42.4)              38 (38.8)              19 (52.8)              7 (63.6)               0.265

   Cerebrovascular disease         10 (30.3)              24 (24.5)              11 (30.6)              0                      0.193

   Neoplasm                        7 (21.2)               14 (14.3)              8 (22.2)               1 (9.1)                0.547

   Liver disease                   2 (6.1)                5 (5.1)                2 (5.6)                0                      0.879

   Heart failure                   8 (24.2)               17 (17.3)              5 (13.9)               4 (36.4)               0.319

   Chronic renal failure           5 (15.2)               14 (14.3)              7 (19.4)               3 (27.3)               0.669

  Smoking (pack years)             0 (0--20.5)            0 (0--30.0)            0 (0--3.0)             0 (0--30.0)            0.561

  Primary site of infection                                                                                                    

   Lung                            27 (81.8)              69 (70.4)              27 (75.0)              8 (72.7)               0.637

   Abdomen                         2 (6.1)                9 (9.2)                3 (8.3)                1 (9.1)                0.956

   Urinary tract                   1 (3.0)                9 (9.2)                2 (5.6)                1 (9.1)                0.656

   Gastrointestinal tract          2 (6.1)                6 (6.1)                3 (8.3)                1 (9.1)                0.955

   Other site                      1 (3.0)                5 (5.1)                1 (2.8)                0                      0.800

  Community-acquired infection     25 (75.8)              76 (77.6)              26 (72.2)              8 (72.7)               0.925

  Hypotension                      19 (57.6)              34 (34.7)              9 (25.0)               1 (9.1)                0.007

  Lactate level (mmol/L)           2.4 (1.6--7.2)         2.1 (1.0--4.3)         1.6 (1.2--3.3)         1.9 (0.6--2.9)         0.201

  Oliguria                         8 (24.2)               13 (13.3)              3 (8.3)                0                      0.121

  Pao~2~/Fio~2~ (mm Hg)            180.0 (113.5--251.0)   164.5 (102.3--240.5)   188.0 (140.5--268.5)   215.0 (153.0--300.0)   0.340

  Serum creatinine (µmol/L)        89.0 (57.0--127.0)     118.5 (72.5--190.5)    91.0 (60.0--212.5)     86.0 (56.0--112.0)     0.136

  Total bilirubin (µmol/mL)        18.0 (10.1--33.1)      14.4 (10.1--28.4)      17.2 (12.2--26.3)      15.2 (11.3--20.0)      0.819

  Platelets (×10^9^/L)             139.0 (75.0--213.0)    147.0 (86.0--209.8)    182.5 (128.3--253.8)   115.0 (49.0--144.0)    0.056

  INR                              1.3 (1.1--1.6)         1.2 (1.0--1.5)         1.2 (1.1--1.3)         1.1 (1.0--1.2)         0.269

  Glasgow Coma Scale               13.0 (10.0--15.0)      15.0 (12.0--15.0)      15.0 (11.0--15.0)      13.0 (10.0--15.0)      0.761

  SOFA score                       8.0 (5.0--11.0)        7.0 (5.0--9.0)         6.0 (4.0--8.0)         5.0 (5.0--8.0)         0.382

  APACHE II score                  18.0 (16.0--24.0)      19.0 (13.0--25.0)      18.0 (13.0--22.0)      14.0 (9.0--17.0)       0.060

  Septic shock                     19 (57.6)              30 (30.6)              9 (25.0)               1 (9.1)                0.004

  Non-invasive ventilation         7 (21.2)               30 (30.6)              10 (27.8)              5 (45.5)               0.466

  Intubated                        19 (57.6)              43 (43.9)              13 (36.1)              4 (36.4)               0.305

  Positive blood culture           7 (21.2)               24 (24.5)              4 (11.1)               3 (27.3)               0.383

  Length of ICU stay (days)        10.0 (4.0--25.0)       13.0 (7.0--25.0)       11.0 (4.0--19.0)       9.0 (6.0--13.0)        0.461

  Length of hospital stay (days)   13.0 (4.0--29.0)       16.0 (10.0--28.0)      16.0 (8.0--32.0)       13.0 (8.0--20.0)       0.813

  In-hospital mortality            20 (60.6)              41 (41.8)              11 (30.6)              2 (18.2)               0.027

  90-day mortality                 22 (66.7)              47 (48.0)              13 (36.1)              2 (18.2)               0.015
  ---------------------------------------------------------------------------------------------------------------------------------------

Data are presented as n (%) or median (IQR).

APACHE, Acute Physiology and Chronic Health Evaluation; COPD, Chronic obstructive pulmonary disease; ICU, intensive care unit; INR, international normalised ratio; SOFA, Sequential Organ Failure Assessment.

Kaplan-Meier survival curves were constructed to show the survival probabilities at day 90 according to BMI classification, and these were compared using the log rank test, which also showed that higher BMI was associated with better prognosis (p=0.008) ([figure 2](#F2){ref-type="fig"}).

![Kaplan-Meier survival plot for 90-day survival of underweight, normal weight, overweight and obese patients with sepsis.](bmjopen-2018-021979f02){#F2}

Discussion {#s4}
==========

This prospective observational cohort study focused on medical patients with sepsis admitted to the ICU, and the results showed that besides SOFA score and APACHE II score, BMI was identified as an independent factor for 90-day mortality by Cox regression analysis. The association of SOFA and APACHE II score with mortality in this cohort was consistent with previous studies.[@R16] This study adds the finding that BMI was independently associated with survival, where 90-day mortality decreased with an increase in BMI. While studies examining the risk factors associated with outcomes in sepsis reached inconsistent conclusions on the association of BMI with mortality, our results confirmed that BMI was independently associated with mortality in patients with sepsis caused by medical conditions.

Globally, the prevalence of obesity has reached epidemic proportions, especially in developed countries.[@R19] BMI is still a useful proxy of overall health because it is highly correlated with body surface area, which is commonly used as a surrogate measure in obesity classification. Even though it is widely accepted that obesity is a risk factor for diabetes mellitus, hypertension and cardiovascular diseases, the present study and several other studies have indicated that overweight and obese patients with sepsis tend to experience lower mortality. This has been called the 'obesity paradox'.[@R5] Although some researchers have expressed doubt that the true paradox may lie in the variations in sepsis interventions,[@R6] a meta-analysis concluded that individuals who were overweight or obese had a reduced adjusted mortality when admitted to the ICU with sepsis or septic shock.[@R8] Recently, another meta-analysis also concluded that being overweight was associated with lower mortality (OR 0.87, 95% CI 0.77 to 0.97, p=0.02) compared with obese (OR 0.89, 95% CI 0.72 to 1.10, p=0.29) and morbidly obese (OR 0.64, 95% CI 0.38 to 1.08, p=0.09) patients who did not exhibit significantly reduced mortality compared with normal weight patients.[@R12] In a large and nationally representative sample of over 1000 hospitals in the USA, obesity was found to be significantly associated with a 16% decrease in the odds of dying among patients with sepsis who were hospitalised.[@R22]

Underweight patients with sepsis may be more common in developing countries than in developed countries. In the present study, the percentages of underweight, normal weight, overweight and obese patients were 18.4%, 55.3%, 20.1% and 6.1%, respectively, while those with sepsis in a study in Canada and the USA represented 6.8%, 35.3%, 28.3% and 29.0%.[@R6] Being underweight was found to be one of the independent risk factors of mortality in a study on the correlation between surgical site infection and mortality.[@R10] Furthermore, Lee *et al* [@R11] also reported that being underweight was associated with mortality in patients with severe sepsis and septic shock. However, BMI has not been shown to be an independent factor for clinical outcomes by multivariable analyses. In our cohort of medical patients with sepsis, which mainly included elderly and less obese patients, BMI was identified as an independent factor for survival, patients with lower BMI having a higher risk of death. Thus, our findings would be helpful for evaluating the clinical outcomes of medical patients with sepsis, although validation in future large sample, multi-centre studies is still needed.

The mechanism of the correlation between BMI and mortality of sepsis is unclear. There are several potential reasons that could explain this. First, higher BMI resulted in more fat reserves, and patients could have a greater capacity to cope with the inflammatory response during sepsis and sepsis-associated acute lung injury.[@R23] Furthermore, they may be able to tolerate extensive weight loss and dysfunction associated with critical illness.[@R26] Second, a higher BMI can lead to an increased level of lipoproteins. High-density lipoproteins may bind and inactivate lipopolysaccharide or other harmful bacterial products released during sepsis[@R27] and modulate adhesion molecule expression, upregulate endothelial nitric oxide synthase and counteract oxidative stress.[@R28] Third, higher BMI can lead to increased adipose tissue deposition. Adipose tissue is increasingly being considered as a functional endocrine organ and associated with increased renin--angiotensin system activity.[@R29] It appears to have protective haemodynamic effects during sepsis and may decrease the need for fluid or vasopressor support.[@R21]

In general, sex has not been found to be an independent predictor for survival in patients with sepsis, which is the same as the results of our current study. But in some special populations, for example in patients with liver cirrhosis with bloodstream infection, male sex may be an independent risk factor for mortality.[@R31]

As the relationship between BMI and clinical outcomes of sepsis may be related partly to differences in patient characteristics, we therefore set out to evaluate the impact of BMI on survival in a cohort of medical patients with sepsis, which is different from surgical septic patients. Ranieri *et al* [@R32] reported that the primary sites of infection in adults with septic shock were lung (43.9%), abdomen (30.0%), urinary tract (12.3%), skin (5.5%) and other sites (8.3%). Scheer *et al* [@R33] found that the most common primary site of infection was different between medical and surgical patients. In medical patients, the lung was the most common primary site (42.0%--56.7%), while it was abdomen (48.4%--64.4%)%) in surgical patients. It should be noted that in the majority of our patients (73.6%), sepsis was associated with pulmonary infection, a much higher percentage as compared with other studies. He et al[@R34] reported that pulmonary sepsis showed worse outcome than abdominal sepsis, and pulmonary infection was a risk factor for 1-year mortality and quality of life after sepsis.

There were several limitations to our study. First, the BMI of our patients ranged from 12.11 to 32.46. There was no morbidly obese patient in the current study. In fact, morbidly obese people are rare in this country. Ten severely underweight patients with BMI \<16.0 were included in the present study, which introduces possible sample bias in patients in the low BMI category. However, the 90-day and in-hospital mortality of these 10 severely underweight patients were 70.0% and 60.0% respectively, not significantly different from that of all 33 underweight patients (66.7% and 60.6%, respectively). Second, the present study used weight ascertained at ICU admission, rather than the patient's baseline outpatient body weight. This practice may misclassify the BMI category in as many as 21.9% of patients due to lack of fluid balance adjustment.[@R35] Third, BMI was used to determine the nutritional status of patients in this study. BMI is a simple index and widely used in clinical practice, but other indices such as percent body fat might better reflect body composition.[@R36] Finally, it was a single-centre study with 178 participants, and a large proportion of our patients were older than 65 years, which may have led to a sample-related bias.

Conclusions {#s5}
===========

To our knowledge, this is the first prospective cohort study that focused on medical patients with sepsis, showing that BMI was independently associated with 90-day survival, with patients having a lower BMI at a higher risk of death.

Supplementary Material
======================

###### Reviewer comments

###### Author\'s manuscript

**Contributors:** QTZ, YCS, YAZ: designed the study. QTZ, YCS, NS, YAZ, QBM: coordinated the study. MW, JZ, YLD, SL, HXG: were responsible for patient screening, enrollment and follow-up. QTZ, MW, YCS: analysed the data. QTZ: drafted the manuscript. YCS: critically revised the manuscript. All authors had full access to all study data, read and approved the final version of the manuscript.

**Funding:** This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

**Competing interests:** None declared.

**Patient consent:** Not required.

**Ethics approval:** The study protocol was approved (approval number M2015021) by the ethics committee of Peking University Third Hospital, Beijing, China.

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Data sharing statement:** The authors declare that all data supporting the findings of this study are available within the article.
